Emmanuelle Marie Charpentier
Personal Information
Born: 1968
Country of Birth: France
Nationality: France
Ethnicity: White
Education
1995, BSc,MSc & DPhil, Sorbonne University, Pierre & Marie Curie Campus Pasteur Institute, Research PhD
Professional Life
Field of Study: Microbiology; Genetics
Institution/Corporation: University of Berlin; Umea University, Sweden; Max Planck Society
Degrees & Memberships: 10 honorary doctorate degrees; Member of : 2014, European Molecular Biology Organisation, 2015, National Academy of Sciences Leopoldina, 2016, Berlin-Brandenberg Academy of Sciences, 2016, Austrian Academy of Sciences. 2016, Royal Swedish Acadey of Sciences, 2017, US National Academy of Sciences, Foreign Associate, 2017, National Academy of Technologies of France, 2017, French Academie des Sciences, 2018, European Academy of Sciences & Art, 2021, Pontifical Academy of Sciences
Awards & Achievements
Awards: 2020, Nobel Prize in Chemistry (with Jennifer Doudna); 2020, Wolf Prize in Medicine (with Doudna); 2015, Louis-Jeantet Prize for Medicine;2015, Breakthrough Prize in Life Science; 2015, Princess of Asturias Award (w/Doudna); 2016, Tang Prize in Pharmaceutical Science (w/Feng Zhang & Doudna); 2016, Canada Gairdner International Award (w/Zheng & Doudna); 2016, Liebniz Prize, German Research Foundation; 2017, Pour le Merite; 2017, Japan Prize (w/Doudna); 2017, The Novozymes Prize; 2018, Kavli Prize in Nanoscience (w/Doudna & Virginijus Siksnys); 2009, Theodor Korner Prize for Science & Culture; 2011, The Fernstrom Prize for Young & Promising Scientists; 2014, Alexander von Humboldt Professorship; 2014, The Goran Gustafsson Prize for Molecular Biology, Royal Swedish Academy of Sciences; 2014, Dr. Paul Janssen Award for Biomedical Research (w/Doudna); Time 100: Pioneer (w/Doudna); 2015, The Ernst Jung Prize in Medicine; 2015, Gruber Foundation International Prize in Genetics(w/Doudna); 2015, Carus Medal, German National Academy of Science, Leopoldina; 2015, Massry Prize; 2015, The Family Hansen Award; 2016, Otto Warburg Medal; 2016, L Oreal-UNESCO For Women in Science Award; 2016, Warren Alpert Foundation Prize; 2016, Paul Ehrlich & Ludwig Darmstaedeer Prize (w/Doudna); 2016, HFSP Naksone Award (w/Doudna); 2016, Knight (Chevalier) French National Order of the Legion of Honour; 2016, Meyenburg Prize; 2016, Wilhelm Exner Medal; 2016, John Scott Award; 2017, BBVA Foundation Frontiers of Knowledge Award (w/Doudna & Francisco Mojica); 2017, Albany Medical Center Prize (w/Doudna, Luciano Maraffini, Mojica & Zhang); 2018, Austrian Decoration for Science & Art; 2018, Bijvoet Medal, Bijvoet Center for Biomolecular Research Utrecht University; 2018, Harvey Prize (w/Doudna & Zhang); 2019, Scheele Award of the Swedish Pharmaceutical Society; 2019, Knight Commander s Cross of the Order of Merit of the Federal Republic of Germany;
Achievements: CRISPR-Cas9 Gene Editing; 2015, Director of Max Planck Institute for Infection Biology/Berlin; 2018, founded independent research institute, Max Planck Unit for the Science of Pathogens; 2013, co-founded CRISPR Therapuetics & ERS Genomics; won the 1st Nobel Prize in Science ever awarde to just 2 females;
2020, with Jennifer Doudna won the Nobel Prize in Chemistry for CRISPR/Cas9; the 1st Nobel science prize only awarded to 2 women
2018, founded an independent research institute, The Max Planck Unit for the Science of Pathogens, in Berlin
Holds 55 patents